TY - JOUR T1 - Survey of Attitudes on Personal Protection Interventions Against COVID-19 Including MMR Vaccination and Future Anti-COVID Vaccines JF - medRxiv DO - 10.1101/2020.10.21.20215251 SP - 2020.10.21.20215251 AU - Joseph D. Schulman AU - James N. Cooper AU - Gary W. Crooks Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/23/2020.10.21.20215251.abstract N2 - An electronic survey was conducted in October, 2020 among individuals primarily age 60 and older regarding their degree of confidence of deriving personal protection from 8 different anti-COVID interventions – social isolation, lockdowns, avoiding restaurants, taking MMR vaccine, wearing masks when indoors with others, avoiding hotels, avoiding commercial air travel, and using the first future specific anti-COVID vaccine. Responses were received from 135 persons from many different U.S. regions and 5 foreign countries. Respondents were generally individuals with very high levels of education and personal achievement. Results demonstrated wide diversity of responses regarding each of these interventions. None were strongly supported by a majority of respondents, but those receiving the largest proportions of strong support were social isolation (41%), wearing masks indoors (41%), and using the first anti-COVID vaccine (41%). MMR (measles-mumps-rubella) vaccination was viewed much more positively than negatively but had the highest proportion of individuals who felt they had insufficient data to formulate an opinion. The largest number of strong negative assessments were toward lockdowns (37%). We speculate that the wide variation in perception of possible benefits from the surveyed interventions, most of which have been widely practiced by or imposed upon millions of individuals, in this highly accomplished older population at increased personal risk from COVID-19 reflects the current absence of rigorous scientific proof of the efficacy of any these interventions, and the continuation of the epidemic despite the widespread utilization of most of them.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo third party, external, or institutional funds were utilized for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was unanimously given by the Ethics Committee of Genetics & IVF Institute. Members and affiliations are as follows: Laurence Udoff, MD, Medical Director, Fairfax Eggbank. Harvey Stern, MD, PhD, Medical Director, Fairfax Cryobank. Sarah Crumbley, RN, Director of Nursing, Genetics & IVF Institute. Melissa Iwaszko, MSc, Laboratory Director, Genetics and IVF Institute. Sara Kraner, JD, MPH, General Counsel and Compliance Officer, Genetics & IVF Institute.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCopies of all data are available upon request from the corresponding author (JDS). ER -